Calreticulin 3 抗体 (AA 21-385)
Quick Overview for Calreticulin 3 抗体 (AA 21-385) (ABIN2591543)
抗原
See all Calreticulin 3 (CALR3) 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 21-385
- 
                                            特异性
- Human CALR3.
- 
                                            纯化方法
- Affinity purified
- 
                                            免疫原
- 
                        Partial recombinant (aa21-385) from human CALR3 (AAH14595) with GST tag. MW of the GST tag alone is 26 KDa.
 Type of Immunogen: Recombinant protein
- 
                                            亚型
- IgG2b kappa
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- PBS, pH 7.2.
- 
                                            注意事项
- Aliquot to avoid repeated freezing and thawing.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            储存方法
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for at least 1 year.
 
- 
                                            
- 
    - Calreticulin 3 (CALR3)
- 
                                            别名
- CALR3
- 
                                            背景
- 
                        Name/Gene ID: CALR3
 Synonyms: CALR3, Calreticulin 3, Calreticulin-2, Calreticulin-3, Calsperin, CRT2, CT93, CMH19, Cancer/testis antigen 93
- 
                                            基因ID
- 125972
- 
                                            途径
- Activation of Innate immune Response
 抗原
- 
                    
 
                                     
                                     
                                    